Kobayashi Pharmaceutical Co Ltd
TSE:4967

Watchlist Manager
Kobayashi Pharmaceutical Co Ltd Logo
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Watchlist
Price: 5 483 JPY 0.11% Market Closed
Market Cap: 407.6B JPY
Section:
Profitability Summary
Profitability Summary
Past Growth
Margins
Return on Capital
Free Cash Flow
See Also

Profitability Summary

Kobayashi Pharmaceutical Co Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less
0
Revenue
+0%
3Y
+7%
5Y
+5%
10Y
+29%
0
Operating Income
+0%
3Y
-5%
5Y
-3%
10Y
+38%
0
Net Income
+0%
3Y
-49%
5Y
-47%
10Y
-21%

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Kobayashi Pharmaceutical Co Ltd

Revenue
165.6B JPY
Cost of Revenue
-78B JPY
Gross Profit
87.6B JPY
Operating Expenses
-62.7B JPY
Operating Income
24.9B JPY
Other Expenses
-14.8B JPY
Net Income
10.1B JPY

Margins Comparison
Kobayashi Pharmaceutical Co Ltd Competitors

Country Company Market Cap Gross
Margin 		Operating
Margin 		Net
Margin
JP
Kobayashi Pharmaceutical Co Ltd
TSE:4967
407.6B JPY
53%
15%
6%
FR
L'Oreal SA
PAR:OR
194.2B EUR
74%
20%
15%
UK
Unilever PLC
LSE:ULVR
120.9B GBP
45%
18%
9%
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.7T INR
52%
21%
17%
UK
HALEON PLC
LSE:HLN
35B GBP
64%
23%
13%
DE
Beiersdorf AG
XETRA:BEI
26.6B EUR
58%
16%
9%
JP
Kao Corp
TSE:4452
2.8T JPY
39%
9%
7%
US
Estee Lauder Companies Inc
NYSE:EL
20.1B USD
73%
10%
-5%
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR
55%
20%
-3%
CN
Giant Biogene Holding Co Ltd
HKEX:2367
78.5B HKD
82%
44%
37%
IN
Dabur India Ltd
NSE:DABUR
858.6B INR
48%
15%
14%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Kobayashi Pharmaceutical Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
JP
Kobayashi Pharmaceutical Co Ltd
TSE:4967
407.6B JPY
5%
4%
12%
10%
FR
L'Oreal SA
PAR:OR
194.2B EUR
21%
12%
22%
15%
UK
Unilever PLC
LSE:ULVR
120.9B GBP
30%
7%
21%
14%
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.7T INR
21%
14%
21%
18%
UK
HALEON PLC
LSE:HLN
35B GBP
9%
4%
9%
7%
DE
Beiersdorf AG
XETRA:BEI
26.6B EUR
11%
7%
17%
14%
JP
Kao Corp
TSE:4452
2.8T JPY
11%
6%
11%
9%
US
Estee Lauder Companies Inc
NYSE:EL
20.1B USD
-14%
-3%
9%
10%
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR
-3%
-2%
20%
-24%
CN
Giant Biogene Holding Co Ltd
HKEX:2367
78.5B HKD
36%
32%
42%
137%
IN
Dabur India Ltd
NSE:DABUR
858.6B INR
18%
12%
17%
14%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 248,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.